Stem Cell Therapy Market Insights :
Stem Cell Therapy Market is projected to be worth USD 36.09 Billion by 2030, registering a CAGR of 16.4% CAGR during the forecast period (2022-2030), the market was valued at USD 9.20 Billion in 2021. The adipose tissue-derived stem cells segment led stem cell treatment in 2021 and had the greatest revenue share due to the expanding use of these MSCs across a variety of therapeutic applications. As a result of the expanding use of these MSCs for a variety of therapeutic purposes in 2021, the adipose tissue-derived stem cells segment dominated stem cell therapy with the greatest revenue share.
Stem Cell Therapy Market Dynamics:
Stem cell therapy (SCT) is use of stem cells to treat a variety of illnesses, from minor to deadly. These stem cells may be obtained from a variety of sources and utilized to treat more than 80 diseases that have received approval.
Driver:
Stem cell therapy sales, demand, and interest in cell-based research have all increased as a result of the need for new and improved treatments for autoimmune, neurological, and cardiovascular problems. Further, the availability of funding for stem cell research is fueling the growth of the stem cell therapy market.
Restraints:
Ethical concerns related to embryonic stem cells, and the absence of specified federal policies that define criteria for funds in therapy development and embryo-based stem cell research which is expected to restrain the stem cell therapy market expansion.
Opportunity:
The use of pluripotent stem cells (iPSCs) in human embryos are avoided, dispelling social and ethical concerns and boosting demand for stem cell therapy along with its sales which are expected to create profitable opportunities for the market.
COVID-19 Analysis of Stem Cell Therapy Market:
The stem cell therapy market has been severely impacted since the COVID-19 epidemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects on China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the Stem Cell Therapy market is moderate. The COVID-19 pandemic has also prompted an increase in the number of clinical trials, with many of these trials looking at the potential of stem cell therapies for the treatment of SARS-CoV-2 infection.
Stem Cell Therapy Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 36.09 |
| CAGR (2022-2030) | 16.4% |
| By Type | Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy |
| By Cell Source | Adipose tissue-derived MSCs (mesenchymal stem cells), Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, and Other Cell Sources |
| By Therapuetic Application | Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other Therapeutic Applications |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Smith+Nephew, MEDIPOST Co, Anterogen.Co., Ltd., CORESTEM, Pharmicell Inc., NuVasive, Inc., RTI Surgical, AlloSource, JCR Pharmaceuticals Co., Ltd., Takeda Pharmaceutical Company Limited, Holostem Terapie Avanzate Srl, Orthofix, Regrow Biosciences Pvt Ltd., and STEMPEUTICS RESEARCH PVT LTD. |
Stem Cell Therapy Market Segment Analysis:
By Type
Based on type, the market for stem cell therapies is divided into allogeneic and autologous stem cell therapies. The market for stem cell therapy was dominated in 2021 by the allogeneic stem therapy segment. The main contributing factor to allogeneic stem cell therapies having the biggest market share is that there are often fewer issues with their development and production. As a result, there are now more clinical studies being conducted to develop allogeneic stem cell therapies, making this the market sector with the quickest growth during the forecast period.
By Cell Source
The stem cell therapy market is divided into, placental/umbilical cord-derived MSCs, adipose tissue-derived MSCs, bone marrow-derived MSCs, and other sources depending on the source of the cells. Due to the expanding use of these MSCs across a variety of therapeutic applications, the adipose tissue-derived stem cells segment led stem cell treatment in 2021 and had the greatest revenue share. The related benefits, including as straightforward isolation techniques, less intrusive harvesting techniques, and comparably higher proliferation capacities, are driving their adoption in the stem cell therapy market.
By Application
The global stem cell treatment market is divided into inflammatory & autoimmune illnesses, surgeries, wounds & injuries, neurological disorders, musculoskeletal disorders, and other therapeutic applications based on therapeutic applications. The therapeutic application segment for musculoskeletal illnesses had the largest revenue in 2021. The main drivers of this share’s income are the high prevalence of musculoskeletal conditions like osteoarthritis and the rising demand for regenerative medicine in orthopedic and sports medicine applications.
By Region
The regional segment includes regions such as Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The major market share, 49.1%, was held by North America in 2021. The region’s expansion can be attributed to several factors, including the presence of major companies working on stem cell therapies, widespread R&D, sophisticated healthcare infrastructure, supportive improvements from healthcare organizations, and robust reimbursement policies. Due to government programs and the nation’s significant scientific activity, the US is dominating the regional market of stem cell therapy.
Stem Cell Therapy Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Type launches have accelerated the growth of the Stem Cell Therapy Market. Key players in the market include-
- Smith+Nephew
- AlloSource
- MEDIPOST Co
- Co., Ltd.
- CORESTEM
- Pharmicell Inc.
- NuVasive, Inc.
- RTI Surgical
- JCR Pharmaceuticals Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Holostem Terapie Avanzate Srl
- Orthofix
- Regrow Biosciences Pvt Ltd.
- STEMPEUTICS RESEARCH PVT LTD.
Recent development
- The Phase 3 clinical trial for NeuroNata-R was still accepting volunteers as of July 2022 according to CORESTEM (South Korea). In South Korea, this medication has been given conditional permission for the treatment of ALS patients.
- Intravenous allogeneic mesenchymal stem cells (MSCs) were approved as an investigational new drug (IND) by the US FDA in September 2020 for the treatment of moderate to severe COVID-19.
- Pluristem Israel and Abu Dhabi Stem Cells Center (UAE) began working together in August 2020 to develop stem cell therapies for the treatment of COVID-19.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Stem Cell Therapy
- Global Stem Cell Therapy Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Stem Cell Therapy Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Therapeutic
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Type Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Stem Cell Therapy Market demand
- Post-Covid Impact on Stem Cell Therapy Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Stem Cell Therapy Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Type
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- By Cell Source
- Adipose tissue-derived MSCs (Mesenchymal Stem Cells),
- Bone marrow-derived MSCs,
- Placental/umbilical cord-derived MSCs, and
- Other Cell Sources
- By Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Cardiovascular Diseases
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- By Type
- Global Stem Cell Therapy Market Overview, By Region
- North America Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Type
- By Cell Source
- By Therapeutic Application
- Canada
- Mexico
- US
- Europe Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Stem Cell Therapy Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Stem Cell Therapy Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Hologic, Inc.
- Business Overview
- Business Financials (USD Billion)
- Type Category, Source, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Smith+Nephew
- MEDIPOST Co
- Co., Ltd.
- CORESTEM
- Pharmicell Inc.
- NuVasive, Inc.
- RTI Surgical
- AlloSource
- JCR Pharmaceuticals Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Holostem Terapie Avanzate Srl
- Orthofix
- Regrow Biosciences Pvt Ltd.
- STEMPEUTICS RESEARCH PVT LTD
- Hologic, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.